ESR1 and breast carcinoma: Moreover, we observed an enriched binding of PR, estrogen receptor (ER), and p300 at the SGK1 genomic locus to enhance the expression of SGK1; this finding corroborates with previous analyses that progesterone alters the ER genomic activity in breast cancer [12].